tiprankstipranks
Trevi Therapeutics (TRVI)
:TRVI
US Market
Holding TRVI?
Track your performance easily

Trevi Therapeutics (TRVI) Technical Analysis

405 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Trevi Therapeutics’s (TRVI) Moving Averages Convergence Divergence (MACD) indicator is 0.10, suggesting Trevi Therapeutics is a Buy.
Trevi Therapeutics’s (TRVI) 20-Day exponential moving average is 3.90, while Trevi Therapeutics’s (TRVI) share price is $3.76, making it a Sell.
Trevi Therapeutics’s (TRVI) 50-Day exponential moving average is 3.62, while Trevi Therapeutics’s (TRVI) share price is $3.76, making it a Buy.

Trevi Therapeutics (TRVI) Pivot Points

Jan 22, 2025, 07:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.55
3.64
3.71
3.80
3.87
3.96
4.03
Fibonacci
3.64
3.70
3.74
3.80
3.86
3.90
3.96
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Trevi Therapeutics (TRVI) Moving Averages

Jan 22, 2025, 07:59 AM
Period
Simple
Exponential
MA5
3.86Sell
3.84Sell
MA10
4.01Sell
3.93Sell
MA20
4.08Sell
3.90Sell
MA50
3.43Buy
3.62Buy
MA100
3.29Buy
3.36Buy
MA200
3.04Buy
3.08Buy
Trevi Therapeutics’s (TRVI) 10-Day exponential moving average is 3.93, while Trevi Therapeutics’s (TRVI) share price is $3.76, making it a Sell.
Trevi Therapeutics’s (TRVI) 100-Day exponential moving average is 3.36, while Trevi Therapeutics’s (TRVI) share price is $3.76, making it a Buy.
Trevi Therapeutics’s (TRVI) stock price is $3.76 and Trevi Therapeutics’s (TRVI) 50-day simple moving average is 3.43, creating a Buy signal.
Trevi Therapeutics’s (TRVI) stock price is $3.76 and Trevi Therapeutics’s (TRVI) 100-day simple moving average is 3.29, creating a Buy signal.
Trevi Therapeutics’s (TRVI) stock price is $3.76 and Trevi Therapeutics’s (TRVI) 200-day simple moving average is 3.04, creating a Buy signal.

Trevi Therapeutics (TRVI) Technical Indicators

Jan 22, 2025, 07:59 AM
Name
Value
Implied Action
RSI (14)
48.03
Neutral
STOCH (9,6)
14.84
Buy
STOCHRSI (14)
14.84
Buy
MACD (12,26)
0.10
Buy
ADX (14)
24.99
Neutral
Williams %R
-87.70
Buy
CCI (14)
-138.19
Buy
ATR (14)
0.31
-
Ultimate Oscillator
41.29
Neutral
ROC
-10.69
Sell
Trevi Therapeutics’s (TRVI) Relative Strength Index (RSI) is 48.03, creating a Neutral signal.
Trevi Therapeutics’s (TRVI) Trend Strength Indicator (ADX) is 24.99, creating a Neutral signal.
Trevi Therapeutics’s (TRVI) Commodity Channel Index (CCI) is -138.19, creating a Buy signal.
Trevi Therapeutics’s (TRVI) Price Rate of Change (ROC) is -10.69, creating a Sell signal.

FAQ

Is TRVI a Buy, Hold, or Sell?
Based on TRVI’s technical indicators, TRVI is a Buy.
    What is TRVI’s RSI (14)?
    TRVI’s RSI (14) is 48.03, which suggests TRVI is a Neutral.
      What is TRVI’s MACD?
      TRVI’s MACD is 0.10, which suggests TRVI is a Buy.
        What is TRVI’s 5-day moving average?
        TRVI’s 5-day moving average is 3.86, which suggests TRVI is a Sell.
          What is TRVI’s 20-day moving average?
          TRVI 20-day moving average is 4.08, which suggests TRVI is a Sell.
            What is TRVI’s 50-day moving average?
            TRVI’s 50-day moving average is 3.43, which suggests TRVI is a Buy.
              What is TRVI’s 200-day moving average?
              TRVI’s 200-day moving average is 3.04, which suggests TRVI is a Buy.
                What is TRVI’s Williams % R (14)?
                TRVI’s Williams % R (14) is -87.70, which suggests TRVI is a Buy.
                  What is TRVI’s CCI (14)?
                  TRVI’s CCI (14) is -138.19, which suggests TRVI is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis